Publikace
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | 2. lékařská fakulta
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis2012 | 2. lékařská fakulta
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | 2. lékařská fakulta
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis2010 | 2. lékařská fakulta
- Současné možnosti léčby roztroušené sklerózy2010 | 2. lékařská fakulta
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | 2. lékařská fakulta
- Intravenous immunoglobulin in relapsing-remitting multiple sclerosis - A dose-finding trial2008 | 2. lékařská fakulta
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | 2. lékařská fakulta
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | 2. lékařská fakulta
- Nálezy v mozkomíšním moku u nemocných s neuroboreliózou léčených ceftizoximem1997 | 2. lékařská fakulta, Ústřední knihovna
Loading network view...